Alector (ALEC) Assets Average (2019 - 2026)
Alector's (ALEC) quarterly Assets Average came in at $221.4 million in Q2 2026, down 42.1% year-over-year from $382.4 million in Q2 2025, and down 16.95% quarter-over-quarter from $266.6 million in Q1 2026.
Analysis
Alector (ALEC) Assets Average (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported Assets Average for 8 consecutive years, with $221.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets Average fell 42.1% year-over-year to $221.4 million in Q2 2026; TTM through Jun 2026 was $221.4 million, a 42.1% decrease from a year earlier, with the FY2025 full-year figure at $380.8 million, down 30.14% from the prior year.
- Assets Average was $221.4 million for Q2 2026 at Alector, down from $266.6 million in the prior quarter.
- Over five years, Assets Average peaked at $922.1 million in Q2 2022 and troughed at $221.4 million in Q2 2026.
- A 5-year average of $586.3 million and a median of $615.9 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average jumped 120.2% in 2022 and tumbled 42.1% in 2026, its largest moves.
- Over 5 years, Assets Average stood at $812.3 million in 2022, then dropped by 20.34% to $647.1 million in 2023, then retreated by 23.94% to $492.2 million in 2024, then sank by 36.15% to $314.3 million in 2025, then fell by 29.55% to $221.4 million in 2026.
- The last three Assets Average figures came in at $221.4 million (Q2 2026), $266.6 million (Q1 2026), and $314.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 221.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 221.39 Mn |
| Mar 31, 2026 | 266.58 Mn |
| Dec 31, 2025 | 314.26 Mn |
| Sep 30, 2025 | 345.85 Mn |
| Jun 30, 2025 | 382.36 Mn |
| Mar 31, 2025 | 438.30 Mn |
| Dec 31, 2024 | 492.16 Mn |
| Sep 30, 2024 | 543.38 Mn |
| Jun 30, 2024 | 603.11 Mn |
| Mar 31, 2024 | 628.66 Mn |
| Dec 31, 2023 | 647.11 Mn |
| Sep 30, 2023 | 690.57 Mn |
| Jun 30, 2023 | 728.54 Mn |
| Mar 31, 2023 | 768.00 Mn |
| Dec 31, 2022 | 812.34 Mn |
| Sep 30, 2022 | 863.36 Mn |
| Jun 30, 2022 | 922.06 Mn |
| Mar 31, 2022 | 884.56 Mn |
| Dec 31, 2021 | 834.44 Mn |
| Sep 30, 2021 | 625.67 Mn |